GRACE ACS Risk and Mortality Calculator

ورودی‌های بالینی بیمار

حداقل ۲۰ — حداکثر ۱۰۰ • واحد: years

حداقل ۳۰ — حداکثر ۲۵۰ • واحد: bpm

حداقل ۵۰ — حداکثر ۳۰۰ • واحد: mmHg

حداقل ۰.۳ — حداکثر ۱۵ • واحد: mg/dL

پنل نتیجه و تصمیم بالینی
در انتظار ورودی‌ها
grace score
—points
آماده برای ارزیابی

پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.

طبقات خطر و بازه‌های امتیاز:
  • Very Low Risk0–87
  • Low Risk88–128
  • Intermediate Risk129–149
  • High Risk150–173

Clinical Decision Pathway

Clinical Decision Pathway & Next Steps

Acute Coronary Syndromes & Chest Pain — سندروم‌های حاد کرونری و درد قفسه سینه

Clinical Rationale:

Evaluate acute chest pain with HEART Score and HEART Pathway for early discharge, detect occlusion MI with Sgarbossa and 4-variable anterior STEMI tool, then assess mortality with GRACE and bleeding with CRUSADE.

← Previous Step in PathwayPrior step

Subtle Anterior STEMI Calculator (4-Variable)

ماشین‌حساب STEMI قدامی نامحسوس (۴ متغیره)

Review previous tool

Recommended Clinical Next Steps:

  • CRUSADE Score for Post-MI Bleeding Risk

    امتیاز CRUSADE (ریسک خونریزی پس از MI)

    Why next: Major bleeding risk post-MI and during PCI
Direct Clinical Answer

The GRACE ACS Risk and Mortality Calculator calculates stratifying cardiovascular risk, predicting thromboembolic events, or guiding therapeutic interventions. Key inputs include age. Scores guide initiating guideline-directed medical therapy, antithrombotic or anticoagulant regimens, or urgent coronary angiography. This standardized assessment improves clinical decision safety and bedside patient management.

Clinical Guidelines & Evidence

Estimates admission to 6-month mortality risk for patients with acute coronary syndrome. Uses 8 clinical variables to provide risk stratification and guide treatment decisions in both ST-elevation and non-ST-elevation ACS.

Clinical Indication

The GRACE ACS Risk and Mortality Calculator is indicated for bedside clinical practice to support Estimates admission to 6-month mortality risk for patients with acute coronary syndrome. Uses 8 clinical variables to provide risk stratification and guide treatment decisions in both ST-elevation and non-ST-elevation ACS.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.

Target Population

Target population comprises Adult patients presenting with suspected or established coronary artery disease, cardiac arrhythmias, congestive heart failure, or valvular heart defects. Clinical application is indicated across Emergency department, cardiac care unit (CCU), cardiac catheterization laboratory, and outpatient cardiology clinics.

Limitations & Contraindications

In hemodynamically unstable cardiogenic shock, cardiac arrest, or refractory acute coronary syndromes, immediate resuscitation and coronary angiography supersede scoring.

Clinical Pearls & Action Plan

Continuous 12-lead ECG monitoring, serial cardiac troponin measurements, and echocardiographic evaluation align with ESC/ACC/AHA clinical practice guidelines. Guideline pearl: Recommended by NICE guidelines for ACS risk stratification.

Formula & Variables:

GRACE Score = Age points + Heart Rate points + Systolic BP points + Creatinine points + Killip Class points + (28 × ST deviation) + (14 × Elevated biomarkers) + (39 × Cardiac arrest)

Input Parameters

NameTypeRequiredDescription
ageintegerYesPatient age in years(years)
heart_rateintegerYesHeart rate in beats per minute(bpm)
systolic_bpintegerYesSystolic blood pressure in mmHg(mmHg)
creatininefloatYesSerum creatinine level in mg/dL(mg/dL)
killip_classstringYesKillip class based on signs of congestive heart failure
cardiac_arreststringYesCardiac arrest at admission
st_deviationstringYesST segment deviation on ECG
elevated_biomarkersstringYesElevated cardiac enzymes/biomarkers (troponin, CK-MB)

Score Interpretation & Guidance

RangeStageDescription
0–87Very Low RiskExcellent prognosis
88–128Low RiskGood prognosis
129–149Intermediate RiskModerate prognosis
150–173High RiskPoor prognosis
174–284Very High RiskVery poor prognosis
285–400Extremely High RiskCritical prognosis

Evidence-Based References (EBM)

  • Fox KA, Dabbous OH, Goldberg RJ, Pieper KS, Eagle KA, Van de Werf F, et al. Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE). BMJ. 2006;333(7578):1091. doi: 10.1136/bmj.38985.646481.55.DOI: 10.1136/bmj.38985.646481.55
  • Granger CB, Goldberg RJ, Dabbous O, Pieper KS, Eagle KA, Cannon CP, et al. Predictors of hospital mortality in the global registry of acute coronary events. Arch Intern Med. 2003;163(19):2345-53. doi: 10.1001/archinte.163.19.2345.DOI: 10.1001/archinte.163.19.2345
  • Abu-Assi E, Gracía-Acuña JM, Peña-Gil C, González-Juanatey JR. Validation of the GRACE risk score for predicting death within 6 months of follow-up in a contemporary cohort of patients with acute coronary syndrome. Rev Esp Cardiol (Engl Ed). 2010;63(6):640-8. doi: 10.1016/s1885-5857(10)70139-4.DOI: 10.1016/s1885-5857(10)70139-4
  • NICE Clinical Guideline 167. Myocardial infarction with ST-segment elevation: acute management. National Institute for Health and Care Excellence; 2013.

Related calculators